129 related articles for article (PubMed ID: 11199350)
1. Recombinant human erythropoietin therapy for autologous blood donation in rheumatoid arthritis patients undergoing total hip or knee arthroplasty.
Matsuda S; Kondo M; Mashima T; Hoshino S; Shinohara N; Sumida S
Orthopedics; 2001 Jan; 24(1):41-4. PubMed ID: 11199350
[TBL] [Abstract][Full Text] [Related]
2. The effects of recombinant human erythropoietin on autologous blood donation in rheumatoid arthritis patients with anaemia.
Matsui H; Shiraishi N; Yasuda T; Nezuka T
Clin Exp Rheumatol; 1999; 17(1):69-74. PubMed ID: 10084035
[TBL] [Abstract][Full Text] [Related]
3. Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery.
Mercuriali F; Gualtieri G; Sinigaglia L; Inghilleri G; Biffi E; Vinci A; Colotti MT; Barosi G; Lambertengh Deliliers G
Transfusion; 1994 Jun; 34(6):501-6. PubMed ID: 8023392
[TBL] [Abstract][Full Text] [Related]
4. [Recombinant human erythropoietin (KRN5702) therapy for autologous blood transfusion in patients with rheumatoid arthritis undergoing joint replacement surgery--a multicenter phase II clinical trial].
Saikawa I; Sugioka Y; Hotokebuchi T; Tsutsui H; Inaba S; Takagishi K; Iwata H; Ogawa R; Kondo M; Ogata K
Ryumachi; 1994 Jun; 34(3):583-93. PubMed ID: 8052924
[TBL] [Abstract][Full Text] [Related]
5. [Recombinant erythropoietin in autologous blood donation].
von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
[TBL] [Abstract][Full Text] [Related]
6. Preoperative use of recombinant human erythropoietin before total joint arthroplasty.
Bezwada HP; Nazarian DG; Henry DH; Booth RE
J Bone Joint Surg Am; 2003 Sep; 85(9):1795-800. PubMed ID: 12954840
[TBL] [Abstract][Full Text] [Related]
7. Autologous blood transfusion with recombinant erythropoietin treatment. 22 arthroplasties for rheumatoid arthritis.
Saikawa I; Hotokebuchi T; Arita C; Inaba S; Shuto T; Tsutsui H; Sugioka Y
Acta Orthop Scand; 1994 Feb; 65(1):15-9. PubMed ID: 8154276
[TBL] [Abstract][Full Text] [Related]
8. Autologous blood transfusion with recombinant erythropoietin treatment in anaemic patients with rheumatoid arthritis.
Tanaka N; Ito K; Ishii S; Yamazaki I
Clin Rheumatol; 1999; 18(4):293-8. PubMed ID: 10468168
[TBL] [Abstract][Full Text] [Related]
9. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients.
So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
Anesthesiology; 2014 Apr; 120(4):839-51. PubMed ID: 24424070
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin for autologous blood donation in total hip arthroplasty patients.
Aksoy MC; Tokgozoglu AM
Arch Orthop Trauma Surg; 2001; 121(3):162-5. PubMed ID: 11262783
[TBL] [Abstract][Full Text] [Related]
11. Predictors of perioperative blood loss in total joint arthroplasty.
Park JH; Rasouli MR; Mortazavi SM; Tokarski AT; Maltenfort MG; Parvizi J
J Bone Joint Surg Am; 2013 Oct; 95(19):1777-83. PubMed ID: 24088970
[TBL] [Abstract][Full Text] [Related]
12. A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty.
Couvret C; Laffon M; Baud A; Payen V; Burdin P; Fusciardi J
Anesth Analg; 2004 Jul; 99(1):262-271. PubMed ID: 15281542
[TBL] [Abstract][Full Text] [Related]
13. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl.
So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
Anesthesiology; 2014 Apr; 120(4):852-60. PubMed ID: 24434302
[TBL] [Abstract][Full Text] [Related]
14. Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion.
Hatzidakis AM; Mendlick RM; McKillip T; Reddy RL; Garvin KL
J Bone Joint Surg Am; 2000 Jan; 82(1):89-100. PubMed ID: 10653088
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin in preoperative autologous blood donation did not influence the haemoglobin recovery after surgery.
Avall A; Hyllner M; Bengtson JP; Carlsson L; Bengtsson A
Acta Anaesthesiol Scand; 2003 Jul; 47(6):687-92. PubMed ID: 12803585
[TBL] [Abstract][Full Text] [Related]
16. Transfusion options in total joint arthroplasty.
Keating EM; Ritter MA
J Arthroplasty; 2002 Jun; 17(4 Suppl 1):125-8. PubMed ID: 12068422
[TBL] [Abstract][Full Text] [Related]
17. An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty.
Stowell CP; Chandler H; Jové M; Guilfoyle M; Wacholtz MC
Orthopedics; 1999 Jan; 22(1 Suppl):s105-12. PubMed ID: 9927110
[TBL] [Abstract][Full Text] [Related]
18. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty.
Green WS; Toy P; Bozic KJ
J Arthroplasty; 2010 Jan; 25(1):93-6. PubMed ID: 19056224
[TBL] [Abstract][Full Text] [Related]
19. Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement.
Gombotz H; Gries M; Sipurzynski S; Fruhwald S; Rehak P
Acta Anaesthesiol Scand; 2000 Jul; 44(6):737-42. PubMed ID: 10903019
[TBL] [Abstract][Full Text] [Related]
20. Blood loss management in high-risk patients undergoing total knee arthroplasty: a comparison of two techniques.
Cushner FD; Lee GC; Scuderi GR; Arsht SJ; Scott WN
J Knee Surg; 2006 Oct; 19(4):249-53. PubMed ID: 17080646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
